← Eichor
Condition: Autoimmune Conditions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autoimmune Conditions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Foot Muscles Training in Sclerosis
NA · 1 location(s) · Inés Llamas-Ramos · NCT06665607A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Phase 1 · 5 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT06880081Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04833465RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
NA · 1 location(s) · Centro de Reabilitacao do Norte · NCT05461898Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NA · 1 location(s) · University of Michigan · NCT07392879A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829Collection and Distribution of Biospecimens for Novel Research Uses
Phase N/A · 2 location(s) · iSpecimen Inc · NCT03848962A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04518475Romiplostim for Oral TPO-RA Resistant ITP
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07612319V-IMMUNE® for Immune Thrombocytopenia
Phase 3 · 2 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06962631A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05214391A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopen
Phase 2/Phase 3 · 20 location(s) · argenx · NCT07194850Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07021456Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
Phase N/A · 2 location(s) · Military Medical Clinical Center of the Southern Region, Ukr · NCT07536841Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Phase N/A · 23 location(s) · argenx · NCT07264426Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
NA · 1 location(s) · University of Colorado, Denver · NCT06297980China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Phase N/A · 1 location(s) · Vastra Gotaland Region · NCT05678374A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Phase 1/Phase 2 · 45 location(s) · Eli Lilly and Company · NCT06721013Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NA · 1 location(s) · Sohag University · NCT07093606French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT02877706Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Phase 1/Phase 2 · 10 location(s) · CRISPR Therapeutics AG · NCT07549698INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Phase 2 · 10 location(s) · Mannkind Corporation · NCT07224321Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1/Phase 2 · 1 location(s) · Thomas Advanced Medical LLC · NCT04684602Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.